Cargando…
Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma
We aimed to comprehensively investigate the clinicopathologic and molecular implications of altered epithelial cell adhesion molecule (EPCAM) expression in colorectal carcinoma (CRC). EPCAM immunohistochemical expression, EPCAM 3′ end deletion, EPCAM promoter methylation, microsatellite instability...
Autores principales: | Kim, Jung Ho, Bae, Jeong Mo, Song, Young Seok, Cho, Nam-Yun, Lee, Hye Seung, Kang, Gyeong Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924648/ https://www.ncbi.nlm.nih.gov/pubmed/26528695 http://dx.doi.org/10.18632/oncotarget.5618 |
Ejemplares similares
-
Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma
por: Yoo, Seung-Yeon, et al.
Publicado: (2019) -
Differential Features of Microsatellite-Unstable Colorectal Carcinomas Depending on EPCAM Expression Status
por: Kim, Jung Ho, et al.
Publicado: (2014) -
Prognostic and clinicopathological significance of Fusobacterium nucleatum in colorectal cancer: a systemic review and meta-analysis
por: Kim, Younghoon, et al.
Publicado: (2022) -
Metaplastic Breast Carcinoma: Clinicopathological Parameters and Prognostic Profile
por: Haroon, Saroona, et al.
Publicado: (2021) -
Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX
por: Park, Hye Eun, et al.
Publicado: (2021)